International Journal of Cardiology
Volume 135, Issue 3 , Pages 287-295, 10 July 2009

Cardiac magnetic resonance imaging at 3 and 15 months after application of circulating progenitor cells in recanalised chronic total occlusions

University of Leipzig — Heart Centre, Department of Internal Medicine/Cardiology, Leipzig, Germany

Received 13 December 2007; accepted 7 March 2008. published online 27 June 2008.

Abstract 

Background

Transplantation of circulating progenitor cells (CPC) improves left ventricular function after successful recanalisation of chronic total occlusions at short-term follow-up. Cardiac magnetic resonance imaging (CMRI) is an excellent tool for serial assessment of underlying structural changes in perfusion, left ventricular function, and infarct size.

Methods

Twenty-eight patients with reperfused chronic total occlusion were randomised to CPC or inactive serum (control) infused into the target vessel. Serial CMRI was performed at baseline, after 3 and 15 months.

Results

Serial CMRI revealed an increase in ejection fraction in CPC (from 51±12% to 58±11% and 59±11%; p<0.01 versus baseline) and a decrease in endsystolic volume (from 74±30 ml to 65±30 ml and 63±31 ml; p<0.05 versus baseline). Infarct size decreased from 14.4±9.3% to 11.6±8.9% and 10.3±8.9% left ventricle (p<0.01 versus baseline). Myocardial perfusion revealed an improvement in affected segments from 1.50±0.17 to 1.76±0.16 and 1.82±0.20 (p<0.001). In control ejection fraction showed no increase at 3 (p=0.99) and a trend towards improvement at 15 months (p=0.07), whereas perfusion improved at 3 (p=0.01) and 15 months (p=0.004) follow-up.

Conclusions

Analysis of serial CMRI suggests that CPC application after chronic total occlusion recanalisation is associated with improved myocardial perfusion, reduction in infarct size and subsequent improved recovery of left ventricular function as compared to control at short- and long-term follow-up.

Keywords: Chronic total occlusion, Myocardial infarction, Magnetic resonance imaging, Percutaneous coronary intervention, Perfusion, Remodeling, Stem cells

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0167-5273(08)00525-1

doi:10.1016/j.ijcard.2008.03.055

International Journal of Cardiology
Volume 135, Issue 3 , Pages 287-295, 10 July 2009